Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an overview of 36 systematic reviews
Paschalis Karakasis, Konstantinos Pamporis, Panagiotis Stachteas, et al.
Heart Failure Reviews (2023) Vol. 28, Iss. 5, pp. 1033-1051
Closed Access | Times Cited: 17

Showing 17 citing articles:

Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella?
Paschalis Karakasis, Nikolaos Fragakis, Κωνσταντίνος Κούσκουρας, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 11, pp. 841-850
Closed Access | Times Cited: 20
Sodium‐glucose cotransporter 2 inhibitors and outcomes in transthyretin amyloid cardiomyopathy: Systematic review and meta‐analysis
Paschalis Karakasis, Panagiotis Theofilis, Dimitrios Patoulias, et al.
European Journal of Clinical Investigation (2025)
Open Access | Times Cited: 2
The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure
Panagiotis Stachteas, Athina Nasoufidou, Dimitrios Patoulias, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3122-3122
Open Access | Times Cited: 14
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure?
Paschalis Karakasis, Nikolaos Fragakis, Dimitrios Patoulias, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2112-2112
Open Access | Times Cited: 14
The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review
Panagiotis Stachteas, Athina Nasoufidou, Efstratios Karagiannidis, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5408-5408
Open Access | Times Cited: 9
Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 209-209
Open Access | Times Cited: 9
Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications
Paschalis Karakasis, Panagiotis Theofilis, Eleftheria Lefkou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2739-2739
Open Access | Times Cited: 1
Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope?
Paschalis Karakasis, Μarios Sagris, Dimitrios Patoulias, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2503-2503
Open Access | Times Cited: 6
An international modified Delphi consensus study on the optimal diagnosis and treatment of patients with HFpEF
Andrew Sindone, Magdy Abdelhamid, Wael Almahmeed, et al.
Current Medical Research and Opinion (2025), pp. 1-17
Closed Access
Sodium-glucose cotransporter 2 inhibitors in transthyretin amyloid cardiomyopathy: navigating potential benefits and uncertainties
Paschalis Karakasis
Current Medical Research and Opinion (2025), pp. 1-9
Closed Access
Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Heart Failure With Preserved Ejection Fraction: A Systematic Review
Manuel Guzmán, Diana M. Torpoco Rivera, Irina Matos Guerrero, et al.
Cureus (2025)
Open Access
Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease
Adina Braha, Bogdan Timar, Viviana Ivan, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 5901-5901
Open Access | Times Cited: 2
Sodium–Glucose Transporter 2 Inhibitors in Heart Failure: An Overview of Systematic Reviews
Yixuan Fang, Lihong Chen, Shiyi Sun, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 7, pp. 198-198
Open Access | Times Cited: 1
Left Ventricular Diastolic Dysfunction across Levels of Kidney Function: A Cross-Sectional Study Based on Routine Clinical Practice Data
Cindy P Porras, Elisa Dal Canto, Anne-Mar L. van Ommen, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5313-5313
Open Access | Times Cited: 1
Comment on “Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): A systematic review and meta-analysis”
Paschalis Karakasis
Current Problems in Cardiology (2024) Vol. 49, Iss. 5, pp. 102520-102520
Closed Access
Update on evidence-based clinical application of sodium-glucose cotransporter inhibitors: Insight to uncommon cardiovascular disease scenarios in diabetes
Shibing Tao, Xi Lu, Zi‐Wei Ye, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 7, pp. 1461-1476
Open Access
Acromegaly in Speckle Tracking Echocardiography—A New Cardiac Hypertrophy Phenotype? Case Report and Review
Alexander Suchodolski, Monika Wójcik-Giertuga, Beata Kos‐Kudła, et al.
Life (2024) Vol. 14, Iss. 11, pp. 1459-1459
Open Access
Potential of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Heart Failure With Preserved Ejection Fraction: A Narrative Review
Abdulaziz Alsuwayh, Mohammed Ahmad Altawili, Marwan Fahad Alhazmi, et al.
Cureus (2024)
Open Access
Page 1

Scroll to top